Table 1. ANOVA: Effects of the experimental temperatures and the site of origin and their interactions on the studied traits of C. fluminea.
Cellular process | Biomarker | Site | Temperature | Site × Temperature |
---|---|---|---|---|
Gill tissue | ||||
OS | Mn-SOD | F1,90 = 28.1 P < 0.001 | F2,90 = 36.2 P < 0.001 | F5,90 = 9.3 P < 0.001 |
OS | Cu,Zn-SOD | F1,90 = 3.9 P = 0.05 | F2,90 = 13.4 P < 0.001 | F5,90 = 1.5 P = 0.202 |
OS | CAT | F1,90 = 0.08 P = 0.772 | F2,90 = 24.1 P < 0.001 | F5,90 = 9.3 P < 0.001 |
OS | GSTμ | F1,90 = 41.2 P < 0.001 | F2,90 = 21.6 P < 0.001 | F5,90 = 12.9 P < 0.001 |
OS | GSTM1 | F1,90 = 2.9 P = 0.095 | F2,90 = 13.1 P < 0.001 | F5,90 = 2.9 P = 0.018 |
OS | GSTS1 | F1,90 = 4.6 P = 0.035 | F2,90 = 0.09 P = 0.914 | F5,90 = 2.3 P = 0.051 |
OS | GPxA | F1,90 = 9.8 P = 0.002 | F2,90 = 9.3 P < 0.001 | F5,90 = 3.0 P = 0.015 |
OS | TPX1 | F1,90 = 30.6 P < 0.001 | F2,90 = 1.3 P = 0.283 | F5,90 = 4.8 P = 0.001 |
OS | TXNLP | F1,90 = 1.0 P = 0.313 | F2,90 = 2.0 P = 0.147 | F5,90 = 9.8 P < 0.001 |
OS | TXNRD1 | F1,90 = 0.89 P = 0.348 | F2,90 = 0.26 P = 0.774 | F5,90 = 9.2 P < 0.001 |
OS | MTs | F1,90 = 0.72 P = 0.400 | F2,90 = 0.40 P = 0.670 | F5,90 = 4.3 P = 0.002 |
CH | HSP90 | F1,90 = 16.8 P < 0.001 | F2,90 = 33.9 P < 0.001 | F5,90 = 3.4 P = 0.008 |
CH | HSC70 | F1,90 = 4.6 P = 0.035 | F2,90 = 0.09 P = 0.914 | F5,90 = 2.3 P = 0.051 |
CH | HSP70* | F1,90 = 18.2 P < 0.001 | F2,90 = 100.9 P < 0.001 | F5,90 = 14.8 P < 0.001 |
CH | HSP60* | F1,90 = 35.6 P < 0.001 | F2,90 = 5.7 P = 0.005 | F5,90 = 22.7 P < 0.001 |
CH | HSP40 | F1,90 = 2.2 P = 0.143 | F2,90 = 11.4 P < 0.001 | F5,90 = 10.9 P < 0.001 |
CH | HSP22* | F1,90 = 9.3 P = 0.003 | F2,90 = 1.1 P = 0.330 | F5,90 = 6.4 P < 0.001 |
Foot muscle tissue | ||||
OS | MDA | F1,54 = 55.0 P < 0.001 | F2,54 = 2.5 P = 0.096 | F5,54 = 4.9 P = 0.001 |
OS | 4-HNE | F1,54 = 53.2 P < 0.001 | F2,54 = 12.5 P < 0.001 | F5,54 = 9.4 P < 0.001 |
OS | PC | F1,54 = 32.2 P < 0.001 | F2,54 = 1.0 P = 0.373 | F5,54 = 1.0 P = 0.438 |
PS | eIF-2α | F1,37 = 10.5 P = 0.003 | F2,37 = 10.4 P = 0.001 | F5,37 = 4.7 P = 0.003 |
PS | p-eIF-2α | F1,38 = 17.0 P < 0.001 | F2,38 = 22.6 P < 0.001 | F5,38 = 23.5 P < 0.001 |
EM | AMPK | F1,39 = 146.3 P < 0.001 | F2,39 = 13.1 P < 0.001 | F5,39 = 7.7 P < 0.001 |
EM | HIF-1 α | F1,34 = 18.0 P < 0.001 | F2,34 = 14.3 P < 0.001 | F5,34 = 28.8 P < 0.001 |
PD | Ubiquitin | F1,54 = 0.04 P = 0.837 | F2,54 = 0.74 P = 0.484 | F5,54 = 4.7 P = 0.002 |
Digestive gland | ||||
EM | PK | F1,90 = 18.7 P < 0.0001 | F2,90 = 1.6 P = 0.1667 | F5,90 = 1.06 P = 0.4081 |
EM | PEPCK | F1,90 = 0.002 P = 0.966 | F2,90 = 0.6 P = 0.7100 | F5,90 = 1.7 P = 0.0784 |
EM | LDH | F1,90 = 8.212 P = 0.0048 | F2,90 = 0.1 P = 0.5494 | F5,90 = 1.5 P = 0.1574 |
EM | PK/PEPCK | F1,90 = 5.7 P = 0.0187 | F2,90 = 1.4 P = 0.2164 | F5,90 = 2.0 P = 0.0332 |
Biomarkers for oxidative stress (OS), molecular chaperones (CH), protein synthesis (PS), protein degradation (PD) and energy metabolism (EM) were assessed. Significant effects (p < 0.05) are shown in bold. * - analyses were conducted on log-transformed data.